References
- Vitali C., Bombardieri S., Jonsson R., Moutsopolous H. M., Alexander E. L., Carsons S. E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002; 61: 554–8
- Trezza M., Krogh K., Egekvist H., Bjerring P., Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999; 34: 409–13
- Wegener M., Adamek R. J., Wedman B., Jergas M., Altmeyer P. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994; 39: 2209–15
- Battle W. M., Snape W. J., Wright S., Sullivan M. A., Cohen S., Meyers A., et al. Abnormal colonic motility in progressive systemic sclerosis. Ann Intern Med 1981; 94: 749–52
- Whitehead W. E., Taitelbaum G., Wigley F. M., Schuster M. M. Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis. Gastroenterology 1989; 6: 428–32
- Weston S., Thumshirn M., Wiste J., Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998; 93: 1085–9
- Agachan F., Chen T., Pfeifer J., Reismann P., Wexner S. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 1996; 39: 581–5
- Howe S Eaker E. Y., Sallustio J. E., Peebles C., Tan E. M., Williams R. C. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994; 94: 761–70
- Goldblatt F., Gordon T. P., Waterman S. A. Antibody‐mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002; 123: 1144–50
- Waterman S. A., Gordon T. P., Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000; 43: 1647–54